Nickerson Joan — SEC Form 4 filings
SEC reporting owner CIK 1964461. 5 Form 4 filings on record with FilingPulse; latest filed 2025-07-28.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-02-16 to 2025-07-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 4,291 shares, $24,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 1,514 shares @ $8.24 ($12,475) in Verve Therapeutics, Inc., filed 2024-04-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Verve Therapeutics, Inc. (VERV) | Chief Administrative Officer | 5 | — | 2 legs · 4,291 sh · $24,000 | 16 |
Form 4 filings — Nickerson Joan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-07-28 | 4 | Verve Therapeutics, Inc. (VERV) | Code (U): 17,420 · Disposition to issuer (D): 225,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 6,630 (derivative) · Disposition to issuer (D): 102,016 (derivative) · +1 more | EDGAR |
| 2025-04-03 | 4 | Verve Therapeutics, Inc. (VERV) | Option exercise (M): 9,315 · Sale (S): 2,777 @ $4.15 · Option exercise (M): 3,315 (derivative) @ $0 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Verve Therapeutics, Inc. (VERV) | Grant/award (A): 225,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Verve Therapeutics, Inc. (VERV) | Option exercise (M): 3,315 · Sale (S): 1,514 @ $8.24 · Option exercise (M): 3,315 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Verve Therapeutics, Inc. (VERV) | Grant/award (A): 125,000 (derivative) @ $0 · Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1964461 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →